Defunct Company
Total Trials
6
As Lead Sponsor
As Collaborator
0
Total Enrollment
381
NCT00076557
Safety of a New Type of Treatment Called Gene Transfer for the Treatment of Severe Hemophilia B
Phase: Phase 1/2
Role: Lead Sponsor
Start: Jan 31, 2004
Completion: Not specified
NCT00364039
Study to Examine the Safety, Tolerability, and Pharmacokinetics of AV650
Phase: Phase 1
Start: Aug 31, 2006
NCT00576277
Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of AV411 in Neuropathic Pain
Start: Sep 30, 2006
Completion: Nov 30, 2007
NCT00456560
AV650 Drug-Drug Interaction Study
Start: Apr 30, 2007
Completion: May 31, 2007
NCT00531466
Safety and Preliminary Effectiveness of AV650 in Patients With Spasticity Due to Spinal Cord Injury
Phase: Phase 2
Start: Sep 30, 2007
Completion: Nov 30, 2008
NCT00532532
Safety and Preliminary Effectiveness of AV650 in Patients With Spasticity Associated With Multiple Sclerosis